[1]杜晓妍,吴 娇.茯苓的化学成分和药理作用研究进展[J].新乡医学院学报,2021,38(5):496-500.[doi:10.7683/xxyxyxb.2021.05.022]
点击复制

茯苓的化学成分和药理作用研究进展
分享到:

《新乡医学院学报》[ISSN:1004-7239/CN:41-1186/R]

卷:
38
期数:
2021年5
页码:
496-500
栏目:
综述
出版日期:
2021-05-05

文章信息/Info

作者:
杜晓妍吴 娇
(新乡医学院药学院,河南 新乡 453003)
关键词:
茯苓化学成分药理作用
分类号:
R284.1
DOI:
10.7683/xxyxyxb.2021.05.022
文献标志码:
A
摘要:
茯苓为我国临床和民间常用的药食同源中药,其化学成分以萜类和多糖为主,具有利尿保肝、抗氧、抗衰老、抗肿瘤、降血脂、抗病毒等药理作用。目前,茯苓已广泛应用于中成药、保健品及化妆品中。本文就近年来茯苓的化学成分和药理作用研究进行综述,以期为更好地发挥茯苓的功效提供科学依据。

参考文献/References:

[1] 马帅,周蓬.茯苓的研究进展[J].食品与药品,2015,17(3):219-223.
[2] 田婷.基于药理学和代谢组学方法研究茯苓和茯苓皮的利尿活性及其对慢性肾脏病防治作用[D].西安:西北大学,2016.
[3] HUANG Q,JIN Y,ZHANG L,et al.Structure,molecular size and antitumor activities of polysaccharides from Poria cocos mycelia produced in fermenter[J].Carbohydrate Polymers,2007,70(3):324-333.
[4] 吴建元,肖玉玲,孙曼春,等.柱前衍生化高效液相色谱法分析茯苓多糖的单糖组成[J].医药导报,2009,28(9):1213-1214.
[5] 李云桥,侯晓华,王艺峰,等.化学修饰的茯苓β-D-葡聚糖结构与抗胃腺癌活性的关系[J].世界华人消化杂志,2012,20(15):1277-1283.
[6] JIN Y,ZHANG L,CHEN L,et al.Effect of culture media on the chemical and physical characteristics of polysaccharides isolated from Poria cocos mycelia[J].Carbohydrate Research,2003,338(14):1507-1515.
[7] 胡康,罗清,朱晓峰,等.茯苓均一多糖的分离纯化及其硫酸化衍生物对人乳腺癌MDA-MB-231细胞迁移的影响[J].中国中药杂志,2019,44(13):2835-2840.
[8] 张俐娜,丁琼,张平义,等.茯苓菌核多糖的分离和结构分析[J].高等学校化学学报,1997,(6):990-993.
[9] 林雨露,张俐娜,金勇,等.人工培养菌种茯苓菌丝体多糖的分离、组成和分子量[J].高分子学报,2003,(1):97-103.
[10] HUANG Q,ZHANG L.Solution properties of (1-->3)-alpha-D-glucan and its sulfated derivative from Poria cocos mycelia via fermentation tank[J].Biopolymers,2005,79(1):28-38.
[11] YIFENG W,MEI Z,DONG R,et al.Chemical components and molecular mass of six polysaccharides isolated from the sclerotium of Poria cocos[J].Carbohydrate research,2004,339(2):327-334.
[12] 刘坤.茯苓多糖PCP-I对炭疽保护性抗原的佐剂效应研究[D].北京:中国人民解放军军事医学科学院,2017.
[13] WU Y,LI S,LI H,et al.Effect of a polysaccharide from Poria cocos on humoral response in mice immunized by H1N1 influenza and HBsAg vaccines[J].Int J Biol Macromol,2016,91:248-257.
[14] ZHANG W,CHEN L,LI P,et al.Antidepressant and immunosu-ppressive activities of two polysaccharides from Poria cocos (Schw.) Wolf[J].Int J Biol Macromol,2018,120:1696-1704.
[15] KUANG L M,JY C J,YUI L C,et al.Purification,structural elucidation,and anti-inflammatory effect of a water-soluble 1,6-branched 1,3-α-d-galactan from cultured mycelia of Poria cocos[J].Food Chemistry,2010,118(2):349-356.
[16] 赵强强.茯苓多糖的抗炎效果及其对小鼠免疫功能影响的初步研究[D].武汉:华中科技大学,2010.
[17] LI X,MA L,ZHANG L.Molecular basis for Poria cocos mushroom polysaccharide used as an antitumor drug in China[J].Prog Mol Biol Transl Sci,2019,163:263-296.
[18] WANG N,ZHANG Y,WANG X,et al.Antioxidant property of water-soluble polysaccharides from Poria cocos Wolf using different extraction methods[J].Int J Biol Macromol,2016,83:103-110.
[19] PU Y,LIU Z,TIAN H,et al.The immunomodulatory effect of Poria cocos polysaccharides is mediated by the Ca2+/PKC/p38/NF-κB signaling pathway in macrophages[J].Int Immunopharmacol,2019,72:252-257.
[20] LEE K Y,YOU H J,JEONG H G,et al.Polysaccharide isolated from Poria cocos sclerotium induces NF-kappaB/Rel activation and iNOS expression through the activation of p38 kinase in murine macrophages[J].Int Immunopharmacol,2004,4(8):1029-1038.
[21] NIE A,CHAO Y,ZHANG X,et al.Phytochemistry and pharmacological activities of Wolfiporia cocos (F.A.Wolf) ryvarden & gilb[J].Front Pharmacol,2020,11:505249.
[22] 马玲,尹蕾,王兵,等.茯苓研究进展[J].亚太传统医药,2015,11(12):55-59.
[23] 王宏侠.茯苓不同药用部位化学成分分析及赤茯苓质量标准研究[D].石家庄:河北医科大学,2016.
[24] 方潇,丁晓萍,陈林霖,等.茯苓皮中三萜类化学成分的HPLC-LTQ-Orbitrap分析[J].时珍国医国药,2019,30(9):2117-2121.
[25] 倪付勇,谢雪,温建辉,等.茯苓非多糖类化学成分的抗补体活性[J].中草药,2019,50(11):2529-2533.
[26] 杨鹏飞.桂枝茯苓胶囊及其单味药茯苓化学成分和生物活性研究[D].北京:北京协和医学院,2012.
[27] TOSHIHIRO A,YUJI N,HARUKUNI T,et al.Triterpene acids from Poria cocos and their anti-tumor-promoting effects[J].J Nat Prod,2007,70(6):948-953.
[28] WANG M,CHEN D Q,CHEN L,et al.Novel RAS inhibitors poricoic acid ZG and poricoic acid ZH attenuate renal fibrosis via a Wnt/beta-Catenin pathway and targeted phosphorylation of smad3 signaling[J].J Agric Food Chem,2018,66(8):1828-1842.
[29] BAOSONG C,JINJIN Z,JUNJIE H,et al.Lanostane triterpenoids with glucose-uptake-stimulatory activity from peels of the cultivated edible mushroom Wolfiporia cocos[J].J Agric Food Chem,2019,67(26):7348-7364.
[30] 廖川,杨迺嘉,霍昕,等.茯苓普通粉挥发性成分研究[J].生物技术,2008,(4):54-56.
[31] LI G,XU M L,LEE C S,et al.Cytotoxicity and dna topoisomerases inhibitory activity of constituents from the sclerotium of Poria cocos[J].Arch Pharm Res,2004,27(8):829-833.
[32] 胡斌,杨益平,叶阳.茯苓化学成分研究[J].中草药,2006,(5):655-658.
[33] 季怀萍,李菁,扬兴华.ICP-AES同时测定茯苓中多种微量元素[J].实用预防医学,2007,14(3):876-877.
[34] 段超,许刚豪,王冬冬,等.茯苓发酵液多糖含量分析及其抗氧化性能研究[J].日用化学品科学,2016,39(2):31-34.
[35] 程水明,桂元,沈思,等.茯苓皮三萜类物质抗氧化活性研究[J].食品科学,2011,32(9):27-30.
[36] WU S J,NG L T,LIN C C.Antioxidant activities of some common ingredients of traditional chinese medicine,Angelica sinensis,Lycium barbarum and Poria cocos[J].Phytother Res,2004,18(12):1008-1012.
[37] FANG C L,PAUL C R,DAY C H,et al.Poria cocos (Fuling) targets TGFbeta/Smad7 associated collagen accumulation and enhances Nrf2-antioxidant mechanism to exert anti-skin aging effects in human dermal fibroblasts[J].Environ Toxicol,2021,36(5):729-736.
[38] LEE S G,KIM M M.Pachymic acid promotes induction of autophagy related to IGF-1 signaling pathway in WI-38 cells[J].Phytomedicine,2017,36:82-87.
[39] JEONG J W,LEE H H,HAN M H,et al.Ethanol extract of Poria cocos reduces the production of inflammatory mediators by suppressing the NF-kappaB signaling pathway in lipopolysaccharide-stimulated RAW 264.7 macrophages[J].BMC Complement Altern Med,2014,14:101.
[40] LI F F,YUAN Y,LIU Y,et al.Pachymic acid protects H9c2 cardiomyocytes from lipopolysaccharide-induced inflammation and apoptosis by inhibiting the extracellular signal-regulated kinase 1/2 and p38 pathways[J].Mol Med Rep,2015,12(2):2807-2813.
[41] HU G S,HUANG C G,ZHANG Y,et al.Accumulation of biomass and four triterpenoids in two-stage cultured Poria cocos mycelia and diuretic activity in rats[J].Chin J Nat Med,2017,15(4):265-270.
[42] WU Z L,REN H,LAI W Y,et al.Sclederma of Poria cocos exerts its diuretic effect via suppression of renal aquaporin-2 expression in rats with chronic heart failure[J].J Ethnopharmacol,2014,155(1):563-571.
[43] 宋京美.基于数据挖掘的中医治疗肝病临床用药规律与作用机制研究[D].北京:北京中医药大学,2019.
[44] 兰量园,吴咖,吴欣谋,等.茯苓多糖保护对乙酰氨基酚暴露胎鼠的分子机制研究[J].中药药理与临床,2019,35(2):52-55.
[45] 陈更新,劳绍贤,黄志新,等.中药对脾胃湿热证患者胃黏膜水通道蛋白3、4基因表达的影响[J].中国中西医结合杂志,2005,(3):199-202.
[46] 李良,袁尔东,苟娜,等.茯苓水提物对幽门螺杆菌的抑制作用和GES-1细胞增殖作用研究[J].现代食品科技,2019,35(10):19-24,147.
[47] 邵璐,刘杨,唐阿梅,等.茯苓甘草汤对功能性消化不良大鼠血清中胃动素、胃泌素及5-羟色胺的影响[J].贵阳中医学院学报,2019,41(5):11-15.
[48] TIAN H,LIU Z,PU Y,et al.Immunomodulatory effects exerted by Poria cocos polysaccharides via TLR4/TRAF6/NF-κB signaling in vitro and in vivo[J].Biomed Pharmacother,2019,112:108709.
[49] 线婷,王荻,刘红柏.黄芪、甘草、茯苓对施氏鲟非特异性免疫功能的影响[J].大连海洋大学学报,2018,33(3):365-369.
[50] 罗心遥.基于谱效关系的茯苓健脾药效物质基础研究[D].武汉:湖北中医药大学,2020.
[51] 徐旭,窦德强.茯苓对免疫低下小鼠免疫增强的物质基础研究[J].时珍国医国药,2016,27(3):592-593.
[52] 郑威.茯苓多糖及其修饰物抗肿瘤作用及机制研究进展[J].健康研究,2011,31(5):379-381.
[53] MIZUNO T,YKOHLUI P,KINOSHITA T,et al.Antitumor activity and chemical modification of polysaccharides from niohshimeji mushroom,tricholma giganteum[J].Biosci Biotechnol Biochem,1996,60(1):30-33.
[54] ROS J L.Chemical constituents and pharmacological properties of Poria cocos[J].Planta Med,2011,77(7):681-691.
[55] JEONG J W,BEAK J Y,KIM K D,et al.Induction of apoptosis by pachymic acid in T24 human bladder cancer cells[J].J Life Sci,2015,25(1):93-100.
[56] LU C,MA J,CAI D.Pachymic acid inhibits the tumorigenicity of gastric cancer cells by the mitochondrial pathway[J].Anticancer Drugs,2017,28(2):170-179.
[57] WANG N,LIU D,GUO J,et al.Molecular mechanism of Poria cocos combined with oxaliplatin on the inhibition of epithelial-mesenchymal transition in gastric cancer cells[J].Biomed Pharmacother,2018,102:865-873.
[58] 张景岳.本草正[M].北京:中国医药科技出版社,2017:73.
[59] 孟美黛,冯彦,王鹏,等.茯苓极性提取物对CUMS大鼠神经递质及昼夜节律调节的实验研究[J].中草药,2020,51(1):118-126.
[60] 李明玉, 徐煜彬, 徐志立,等.茯苓改善学习记忆及镇静催眠作用研究[J].辽宁中医药大学学报,2014,16(5):25-26.
[61] 吴科锐,韩凌.羧甲基茯苓多糖药理作用研究进展[J].中药材,2017,40(3):744-747.
[62] 陈伟光,张学峰,官莹,等.茯苓酸对小鼠病毒性心肌炎Caspase-3及Akt表达的相关研究[J].心脑血管病防治,2019,19(6):501-503,519,封3.
[63] 张信岳,杨根元,梁丽坚,等.羧甲基茯苓多糖钠体外抗单纯疱疹病毒I型的作用[J].中药新药与临床药理,2003,14(3):161-163.
[64] 王明.茯苓皮抗肾纤维化物质基础及其作用机制研究[D].西安:西北大学,2019.
[65] ZAN J F,SHEN C J,ZHANG L P,et al.Effect of Poria cocos hydroethanolic extract on treating adriamycin-induced rat model of nephrotic syndrome[J].Chin J Integr Med,2017,23(12):916-922.
[66] 邓耒娇,闫洁熙,王沛,等.茯苓多糖对高尿酸血症大鼠肾小管转运体rURAT1、rOAT1和rOCT2表达的影响[J].西部中医药,2019,32(6):10-14.
[67] WANG M,HU H H,CHEN Y Y,et al.Novel poricoic acids attenuate renal fibrosis through regulating redox signalling and aryl hydrocarbon receptor activation[J].Phytomedicine,2020,79:153323.
[68] 郑彩云.茯苓多糖抗糖尿病作用的实验研究[J].中国医疗前沿,2010,5(14):12-13.
[69] 杨瑾,殷智,袁德培,等.液体发酵茯苓胞外多糖的体外降糖效果研究[J].基因组学与应用生物学,2018,37(11):4955-4960.
[70] 杨志娥,任彩丽.桂枝茯苓胶囊联合米非司酮保守治疗子宫肌瘤的临床效果[J].临床医学研究与实践,2020,5(29):87-89.
[71] 陈艳俏,程伟,张成英,等.保元汤合桂枝茯苓丸治疗冠状动脉慢血流临床观察[J].中国中医药现代远程教育,2020,18(19):70-73.
[72] 刘金莲,张建军,刘曦,等.基于辨证保健理论探讨红曲茯苓片对脾虚湿盛型高脂血症大鼠的影响[J].环球中医药,2020,13(11):1837-1845.
[73] 李美丹,姚兰,梁群卿,等.基于网络药理学的防己茯苓汤治疗急性肾损伤机制研究[J].中国中医基础医学杂志,2020,26(9):1371-1377,1422.

相似文献/References:

[1]孙 华,李春燕,薛金涛.葛根的化学成分及药理作用研究进展[J].新乡医学院学报,2019,36(11):1097.[doi:10.7683/xxyxyxb.2019.11.022]
[2]迟宇昊,李 暘,申 远.麦冬化学成分及药理作用研究进展[J].新乡医学院学报,2021,38(2):189.[doi:10.7683/xxyxyxb.2021.02.020]
[3]冬海洋,李彦灵,马矜烁,等.中药牛膝叶化学成分分析[J].新乡医学院学报,2020,37(1):012.[doi:10.7683/xxyxyxb.2020.01.004]
 DONG Haiyang,LI Yanling,MA Jinshuo,et al.Analysis of chemical constituents of Achyranthes bidentata leaf[J].Journal of Xinxiang Medical University,2020,37(5):012.[doi:10.7683/xxyxyxb.2020.01.004]
[4]吴 娇,王 聪.黄芪的化学成分及药理作用研究进展[J].新乡医学院学报,2018,35(9):755.[doi:10.7683/xxyxyxb.2018.09.002]
 N/A.N/A[J].Journal of Xinxiang Medical University,2018,35(5):755.[doi:10.7683/xxyxyxb.2018.09.002]
[5]殷田田,白意晓,庄方方,等.高莴苣化学成分研究[J].新乡医学院学报,2016,33(2):091.[doi:10.7683/xxyxyxb.2016.02.003]
 YIN Tian-tian,BAI Yi-xiao,ZHUANG Fang-fang,et al.Chemical constituents of Lactuca elata[J].Journal of Xinxiang Medical University,2016,33(5):091.[doi:10.7683/xxyxyxb.2016.02.003]
[6]曹 轲,丁明明,庄方方,等.中药糙苏中的环烯醚萜类化合物[J].新乡医学院学报,2016,33(3):164.[doi:10.7683/xxyxyxb.2016.03.002]
 CAO Ke,DING Ming-ming,ZHUANG Fang-fang,et al.Iridoid compounds from Phlomis umbrosa of herb medicine[J].Journal of Xinxiang Medical University,2016,33(5):164.[doi:10.7683/xxyxyxb.2016.03.002]
[7]刘军伟,吕洁丽,张来宾.山药地上部分石油醚部位的化学成分研究[J].新乡医学院学报,2016,33(6):457.[doi:10.7683/xxyxyxb.2016.06.003]
 LIU Jun-wei,LYU Jie-li,ZHANG Lai-bin.Chemical constituents of the petroleum ether fraction from the aerial part of Dioscorea opposita[J].Journal of Xinxiang Medical University,2016,33(5):457.[doi:10.7683/xxyxyxb.2016.06.003]
[8]周慧超,贺 爽,宋 宇,等.全缘橐吾根部化学成分及生物活性研究[J].新乡医学院学报,2016,33(12):1017.[doi:10.7683/xxyxyxb.2016.12.001]
 ZHOU Hui-chao,HE Shuang,SONG Yu,et al.Chemical constituents and biological activity of Ligularia mongolica root[J].Journal of Xinxiang Medical University,2016,33(5):1017.[doi:10.7683/xxyxyxb.2016.12.001]
[9]兰宝恒,吴泽青.柴胡的化学成分及药理作用研究进展[J].新乡医学院学报,2023,40(2):174.[doi:10.7683/xxyxyxb.2023.02.015]
 LAN Baoheng,WU Zeqing.Research progress on chemical constituents and pharmacological action of Bupleurum[J].Journal of Xinxiang Medical University,2023,40(5):174.[doi:10.7683/xxyxyxb.2023.02.015]
[10]肖先,李春燕,刘晓龙,等.甘草的主要化学成分及药理作用研究进展[J].新乡医学院学报,2023,40(3):280.[doi:10.7683/xxyxyxb.2023.03.016]
 XIAO Xian,LI Chunyan,LIU Xiaolong,et al.Research progress of main chemical constituents and pharmacological effects of Glycyrrhizae Radix et Rhizoma[J].Journal of Xinxiang Medical University,2023,40(5):280.[doi:10.7683/xxyxyxb.2023.03.016]

更新日期/Last Update: 2021-05-05